
Glybose 0.3mg Tablet
Marketer
Strides shasun Ltd
Salt Composition
Voglibose (0.3mg)
Overview Glybose 0.3mg Tablet
Acarbose 0.3mg tablets are prescribed for managing type 2 diabetes. This medication aids in regulating elevated postprandial blood glucose. It's indicated when dietary modifications and other antidiabetic agents prove insufficient in controlling hyperglycemia. Administer Acarbose 0.3mg tablets immediately before meals. Dosage and frequency are determined by your physician to optimize glycemic control. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood sugar, risking severe complications such as nephropathy and retinopathy. Treatment necessitates a comprehensive approach incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported adverse effects include increased flatus, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or bothersome side effects to your physician. While Acarbose itself doesn't induce hypoglycemia, concomitant use with other antidiabetic medications (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your doctor of any pre-existing hepatic or renal impairment before commencing treatment. Avoid use if you have bowel inflammation (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals require medical consultation prior to use. Always disclose all medications to your doctor to ensure medication safety. Limit alcohol consumption while using this medication to minimize the hypoglycemia risk.
Uses of Glybose 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Glybose 0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the Glybose 0.3mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
Common Side effects of Glybose 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Glybose 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glybose 0.3mg Tablets should be taken on an empty stomach.
How Glybose 0.3mg Tablet works:
Glucodown 0.3mg tablets are used to manage diabetes. They work by blocking enzymes in the intestines that digest complex carbohydrates into glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glybose 0.3mg Tablets poses a safety risk.
PregnancySAFE IF PRESCRIBED
The use of 0.3mg Glybose tablets during pregnancy is typically regarded as safe. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nonetheless, research involving human subjects is scant.
Breast feedingSAFE IF PRESCRIBED
Lactation and Glybose 0.3mg tablets appear compatible. Available evidence from human studies indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Glybose 0.3mg tablets.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Glybose 0.3mg tablets. A modified Glybose 0.3mg tablet dosage may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using 0.3mg Glybose tablets. Dosage modification may be necessary; physician consultation is recommended.
What if you forget to take Glybose 0.3mg Tablet :
Omit any missed Glybose 0.3mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glybose 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |
